Log in
Enquire now

List of Nerviano Medical Sciences patents

List of Nerviano Medical Sciences patents
List of VideoAmp patents
List of Shenzhen Qiaohua Industries Ltd. patents
List of Standard Bariatrics, Inc patents
List of funding rounds for Wheaton Precious Metals Corporation
List of Techstars Class 22 - Boston 2013 Spring companies
Patents where
Current Assignee
Name
is
Nerviano Medical SciencesNerviano Medical Sciences
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7470543 Methods for identifying ligands using competitive binding

Patent 7470543 was granted and assigned to Nerviano Medical Sciences on December, 2008 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
7470543
December 30, 2008
‌
US Patent 9604980 Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors

Patent 9604980 was granted and assigned to Nerviano Medical Sciences on March, 2017 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9604980
March 28, 2017
‌
US Patent 8927530 Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent

Patent 8927530 was granted and assigned to Nerviano Medical Sciences on January, 2015 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8927530
January 6, 2015
‌
US Patent 9682083 Pyrrolo[2,3-D]pyrimidine derivatives, process for their preparation and their use as kinase inhibitors

Patent 9682083 was granted and assigned to Nerviano Medical Sciences on June, 2017 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9682083
June 20, 2017
‌
US Patent 7482354 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors

Patent 7482354 was granted and assigned to Nerviano Medical Sciences on January, 2009 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
7482354
January 27, 2009
‌
US Patent 11420940 4-carboxamido-isoindolinone derivatives as selective parp-1 inhibitors

Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
11420940
August 23, 2022
‌
US Patent 8993556 Resorcinol derivatives as HSP90 inhibitors

Patent 8993556 was granted and assigned to Nerviano Medical Sciences on March, 2015 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8993556
March 31, 2015
‌
US Patent 9616059 Substituted indazole derivatives active as kinase inhibitors

Patent 9616059 was granted and assigned to Nerviano Medical Sciences on April, 2017 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9616059
April 11, 2017
‌
US Patent 7259244 Human homologue of the DBF4/ASK1 protein, nucleic acids, and methods related to the same

Patent 7259244 was granted and assigned to Nerviano Medical Sciences on August, 2007 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
7259244
August 21, 2007
‌
US Patent 9029356 Substituted indazole derivatives active as kinase inhibitors

Patent 9029356 was granted and assigned to Nerviano Medical Sciences on May, 2015 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9029356
May 12, 2015
‌
US Patent 10081622 Substituted indazole derivatives active as kinase inhibitors

Patent 10081622 was granted and assigned to Nerviano Medical Sciences on September, 2018 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
10081622
September 25, 2018
‌
US Patent 8946226 Use of CDK inhibitor for the treatment of glioma

Patent 8946226 was granted and assigned to Nerviano Medical Sciences on February, 2015 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8946226
February 3, 2015
‌
US Patent 8673893 Substituted indazole derivatives active as kinase inhibitors

Patent 8673893 was granted and assigned to Nerviano Medical Sciences on March, 2014 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8673893
March 18, 2014
‌
US Patent 8969366 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors

Patent 8969366 was granted and assigned to Nerviano Medical Sciences on March, 2015 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8969366
March 3, 2015
‌
US Patent 9102662 Substituted indazole derivatives active as kinase inhibitors

Patent 9102662 was granted and assigned to Nerviano Medical Sciences on August, 2015 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9102662
August 11, 2015
‌
US Patent 9255087 Substituted indazole derivatives active as kinase inhibitors

Patent 9255087 was granted and assigned to Nerviano Medical Sciences on February, 2016 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9255087
February 9, 2016
‌
US Patent 9085558 Substituted indazole derivatives active as kinase inhibitors

Patent 9085558 was granted and assigned to Nerviano Medical Sciences on July, 2015 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9085558
July 21, 2015
‌
US Patent 7399748 Antitumor therapy comprising distamycin derivatives

Patent 7399748 was granted and assigned to Nerviano Medical Sciences on July, 2008 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
7399748
July 15, 2008
‌
US Patent 8470984 Process for the preparation of morpholinyl anthracycline derivatives

Patent 8470984 was granted and assigned to Nerviano Medical Sciences on June, 2013 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8470984
June 25, 2013
‌
US Patent 9637497 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors

Patent 9637497 was granted and assigned to Nerviano Medical Sciences on May, 2017 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9637497
May 2, 2017
‌
US Patent 8299057 Substituted indazole derivatives active as kinase inhibitors

Patent 8299057 was granted and assigned to Nerviano Medical Sciences on October, 2012 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8299057
October 30, 2012
‌
US Patent 8946250 3,4-diarylpyrazoles as protein kinase inhibitors

Patent 8946250 was granted and assigned to Nerviano Medical Sciences on February, 2015 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8946250
February 3, 2015
‌
US Patent 8993594 Isoquinolin-1(2H)-one derivatives as PARP-1 inhibitors

Patent 8993594 was granted and assigned to Nerviano Medical Sciences on March, 2015 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8993594
March 31, 2015
‌
US Patent 9670191 Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors

Patent 9670191 was granted and assigned to Nerviano Medical Sciences on June, 2017 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9670191
June 6, 2017
‌
US Patent 8765972 3-oxo-2,3-dihydro-1

Patent 8765972 was granted and assigned to Nerviano Medical Sciences on July, 2014 by the United States Patent and Trademark Office.

Nerviano Medical Sciences
Nerviano Medical Sciences
United States Patent and Trademark Office
United States Patent and Trademark Office
8765972
July 1, 2014
...
Results per page:
130 results
0 selected
130 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us